Capgemini SE (CAP.PA) • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold CAP.PA in your mock portfolio yet.
The valuation and earnings profile implied by the given PE of 9.62 and EPS of 9.13 suggest Capgemini is solidly profitable and currently priced at a discount to typical global IT services peers. This combination points to healthy underlying earnings power, with the market likely pricing in macro or sector-specific risks rather than a collapse in fundamentals. On balance, the earnings and valuation picture appears supportive for the stock over a medium-term horizon.
Capgemini’s share price at €87.82 is down 15.8% over the last month and trades well below its 200-day moving average of €118.56, indicating a strong recent downtrend and negative momentum. However, the RSI at 30.70 is near oversold territory, suggesting selling pressure may be stretched in the short term. Technically, the setup reflects a weak trend but also a growing probability of a stabilization or relief bounce if no further negative catalysts emerge.
Alternative data for Capgemini SE show a broadly stable to mildly positive operational and brand footprint. Website traffic is substantial, app downloads are robust at roughly 10,000 per day, and job openings remain high at 6,000 with no recent decline, suggesting ongoing demand for talent. Social media trends are mixed but generally stable, pointing to neither a clear surge nor deterioration in broader engagement.
Capgemini SE’s recent share price action is clearly negative, with the stock trading well below its 200-day moving average and having sold off sharply in the last month, but valuation and earnings metrics appear supportive. Alternative data show a stable operating footprint and ongoing hiring, which do not corroborate a severe deterioration in business activity. Overall, the setup looks neutral: the technical trend is bearish, but underlying profitability, valuation, and operational signals provide a counterbalance that could support the stock if sentiment stabilizes.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started